Pdt Partners, LLC Igm Biosciences, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$15.45 - $26.02 $38,393 - $64,659	-2,485 Reduced 18.93%	10,641 $181,000
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $20,847 - $36,517	-1,352 Reduced 9.34%	13,126 $298,000
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $58,799 - $112,990	-4,431 Reduced 23.43%	14,478 $261,000
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $253,758 - $562,164	18,909 New	18,909 $505,000
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $144,505 - $350,611	-3,048 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $131,064 - $256,062	3,048 New	3,048 $225,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.